Yates Anne B
Division of Pediatric Allergy-Immunology, University of Mississippi Medical Center, Jackson, Miss, USA.
Am J Med. 2008 Jul;121(7):572-6. doi: 10.1016/j.amjmed.2007.12.005.
Patients with a history of penicillin allergy pose a treatment dilemma. Unnecessary avoidance of this relatively nontoxic class of drugs exposes the patient to potentially more toxic drugs, increases health care costs, and contributes to the development of antibiotic resistance. Yet for those who truly have allergy or other serious adverse reactions to beta-lactams, the use of alternate drugs is a must. This article reviews current management strategies to determine which patients are good candidates for reintroduction of beta-lactams and which patients should continue avoidance.
有青霉素过敏史的患者面临治疗难题。不必要地避免使用这类相对无毒的药物会使患者接触到潜在毒性更强的药物,增加医疗成本,并促使抗生素耐药性的产生。然而,对于那些确实对β-内酰胺类药物过敏或有其他严重不良反应的患者,必须使用替代药物。本文回顾了当前的管理策略,以确定哪些患者适合重新使用β-内酰胺类药物,哪些患者应继续避免使用。